Program Schedule

Gram-positive Super-bugs

Session: Interactive Session: Antimicrobial Resistance from Hell: A Case-based Symposium
Thursday, October 9, 2014: 2:00 PM
Room: The Pennsylvania Convention Center: Terrace Ballroom-I, II, III, IV
George Eliopoulos, MD, FIDSA, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Principal Investigator/ (Last, first, middle):
Give the following information for the key personnel in the order listed on Form Page 2.
Photocopy this page or follow this format for each person.
George M. Eliopoulos, M.D.
Professor of Medicine, Harvard Medical School
EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training.)
(if applicable)
Harvard University, Boston, Massachusetts
Applied Mathematics
Harvard Medical School, Boston, Massachusetts
RESEARCH AND/OR PROFESSIONAL EXPERIENCE: Concluding with present position, list, in chronological order, previous employment, experience, and honors. Include present membership on any Federal Government public advisory committee. List, in chronological order, the titles, all authors, and complete references to all publications during the past three years and to representative earlier publications pertinent to this application. If the list of publications in the last three years exceeds two pages, select the most pertinent publications. DO NOT EXCEED TWO PAGES.
1996-Active Staff, Beth Israel Deaconess Medical Center, Boston, MA
Professor of Medicine, Harvard Medical School, Boston, MA
Licensure And Certification:
American Board of Internal Medicine
Massachusetts License Registration
Diplomate, Infectious Diseases, American Board of Internal Medicine
Awards And Honors:
Editor-in-Chief, Antimicrobial Agents and Chemotherapy
Chair/ Division A (Antimicrobial Chemotherapy), American Society for Microbiology
Selected Publications:
Meka VG, Pillai SK, Sakoulas G, Wennersten C, Venkataraman L, DeGirolami P, Eliopoulos GM, Moellering RC Jr, Gold HS. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in 23S rRNA gene and loss of a single copy of rRNA. J Infect Dis 2004; 190:311-317.
Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr, Eliopoulos GM. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004; 42:2398-2402.
Meka V, Gold HS, Cooke A, Venkataraman L, Eliopoulos G, Moellering RC Jr, Jenkins S. Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus. J Antimicrob Chemother 2004; 54: 818-820.
Eliopoulos GM, Ferraro MJ, Wennersten CB, Moellering RC Jr. In vitro activity of an oral streptogramin antimicrobial, XRP2868, against gram-positive bacteria. Antimicrob Agents Chemother 2005; 49: 3034-3039
Sakoulas G, Gold HS, Cohen RA, Venkataraman L, Moellering RC Jr, Eliopoulos GM. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteremia. J Antimicrob Chemother 2006; 57: 699-704
Sakoulas G, Alder J, Thauvin-Eliopoulos C, Moellering RC Jr, Eliopoulos GM. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin. Antimicrob Agents Chemother 2006; 50: 1581-1585
Pillai SK, Gold HS, Sakoulas G, Wennersten C, Moellering RC Jr, Eliopoulos GM. Daptomycin non-susceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF. Antimicrob Agents Chemother 2007; 51: 2223-2225.
Tsakris A, Pillai SK, Gold HS, Thauvin-Eliopoulos C, Venkataraman L, Wennersten C, Moellering RC, Jr., Eliopoulos GM. Persistence of rRNA operon mutated copies and rapid r

Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, All Rights Reserved.

Follow IDWeek